Morgan Stanley
MANE icon

Morgan Stanley’s Veradermics Inc MANE Stock Holding History

Morgan Stanley’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33M Buy
75,876
+24,186
+47% +$2.27M ﹤0.01% 3746
2026
Q1 		$3.26M Buy
+51,690
New +$2.61M ﹤0.01% 4418

Other funds holding MANE

Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SR One Capital Management
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Morgan Stanley's MANE Position: Q2 2026 in Review

Morgan Stanley increased its Veradermics Inc (MANE) stake by 47% in Q2 2026, buying an estimated $2.27M and bringing the position to 75,876 shares worth $9.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

Morgan Stanley first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Morgan Stanley held 75,876 shares of Veradermics Inc worth $9.33M as of Q2 2026.
  • Morgan Stanley bought 24,186 Veradermics Inc shares in Q2 2026, an estimated $2.27M.
  • Veradermics Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3746 holding.
  • Morgan Stanley first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.